Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleuroperitoneal shunt for recurrent malignant pleural effusions.

V Tsang1, H C Fernando, P Goldstraw

  • 1Department of Cardiothoracic Surgery, Brompton Hospital, London.

Thorax
|May 1, 1990
PubMed
Summary

Pleuroperitoneal shunts effectively manage malignant pleural effusions, offering palliation for patients with recurrent fluid buildup. This surgical intervention provided significant symptom relief and reduced fluid reaccumulation in most cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sweat Testing in Ireland

Irish medical journal·2018
Same author

Change in biventricular function after cone reconstruction of Ebstein's anomaly: an echocardiographic study.

European heart journal. Cardiovascular Imaging·2017
Same author

BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.

World journal of surgery·2016
Same author

Successful use of infliximab as first line treatment for severe childhood generalized pustular psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

Conclusions from in vitro vs in vivo data.

Perfusion·2014
Same author

Clinical experience with Affinity Pixie oxygenation system in paediatric and infant patients.

Perfusion·2014

Area of Science:

  • Thoracic Surgery
  • Oncology
  • Palliative Care

Background:

  • Malignant pleural effusions present a significant challenge in cancer care.
  • Current therapeutic options for malignant pleural effusions often yield unsatisfactory results.

Purpose of the Study:

  • To evaluate the efficacy of pleuroperitoneal shunts in managing recurrent malignant pleural effusions.
  • To assess the safety and effectiveness of pleuroperitoneal shunting for palliative care in cancer patients.

Main Methods:

  • A cohort of 16 patients with recurrent malignant pleural effusions underwent pleuroperitoneal shunt insertion.
  • Patient outcomes including operative mortality, hospital stay, palliation, shunt complications, and survival were analyzed.

Main Results:

Related Experiment Videos

  • No operative deaths occurred; one perioperative death was attributed to lymphangitis carcinomatosa.
  • Palliation was achieved in 15 out of 16 patients, with no significant reaccumulation of pleural fluid.
  • Two shunts occluded (one due to clots, one due to infection), requiring intervention or alternative treatment.

Conclusions:

  • Pleuroperitoneal shunt insertion is an effective palliative treatment for recurrent malignant pleural effusions.
  • The procedure offers good symptomatic relief and improved quality of life for affected patients.
  • While shunt complications can occur, they are manageable and do not negate the overall benefits of the intervention.